Home › Urogenital Cancer › NCT06795087

Discharge Medication Use Post-Operatively in GU Cancer Patients

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

1. Written informed consent and HIPAA authorization for release of personal health information.
2. Age ≥ 18 years at the time of enrollment
3. Scheduled to undergo surgical cystectomy, partial or total nephrectomy or prostatectomy for a cancer diagnosis.
4. Ability to read and understand the English and/or Spanish language.
5. As determined by the enrolling investigator, ability of the participant to understand and comply with study procedures for the entire length of the study.

Exclusion Criteria:

* None

About the study

The main purpose of this research study is to determine the amount of opioids that are taken after discharge following a cystectomy, nephrectomy (partial or total), or prostatectomy surgeries via a 30-day post- discharge opioid use and disposal survey. We will also evaluate the impact of an opioid disposal education pamphlet on proper disposal of unused opioids.

What is being tested

• Opioid Medication Disposal Education (other)

Sponsor: Wake Forest University Health Sciences · Participants: 684 · Started: Feb 21, 2025

Contact the study team

• Margarita Dzhanumova · Phone: 704-355-2000

Official record on ClinicalTrials.gov — NCT06795087

Locations in the U.S.

Conditions

• Urogenital Cancer

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.